Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 539 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
26 Мб
Скачать
Part III
https://t.me/medicina_free
Emerging Technologies
Bionic Reconstruction: TheNew
https://t.me/medicina_free
Frontier
StefanSalminger, JohannesA.Mayer, andOskarC.Aszmann
12
12.1 Introduction
Brachial plexus lesions including avulsion inju­ries of multiple nerve roots most commonly affect young adults as the vast majority of these patients suffer a motor vehicle accident [1, 2]. In these high-velocity accidents whiplash injuries may result in high traction forces on nerve fasci­cles leading to temporary or even permanent global plexopathies [3, 4]. These disabling inju­ries often have negative social and emotional consequences and are leading to unemployment in this mostly young population [5, 6].
Aside from standard trauma management, the treatment of such complex nerve injuries should be initiated in a timely manner. In patients suffer­ing an avulsion injury of multiple roots, surgical reconstruction focuses on the restoration of a stable shoulder as well as elbow function [79].
S. Salminger · O. C. Aszmann (*) Division of Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria
Christian Doppler Laboratory for Restoration of Extremity Function, Medical University of Vienna, Vienna, Austria e-mail: stefan.salminger@meduniwien.ac.at;
oskar.aszmann@meduniwien.ac.at
J. A. Mayer Christian Doppler Laboratory for Restoration of Extremity Function, Medical University of Vienna, Vienna, Austria e-mail: johannes.mayer@meduniwien.ac.at
Especially after avulsion injuries of the lower roots, return of hand function is hardly ever achieved, resulting in sensory loss, intrinsic wast­ing, and stiffness. The existing secondary recon­structive procedures for brachial plexus injuries that include muscle and tendon transfers, free functional muscle transplantations (FFMT), arthrodesis, tenodesis, or corrective osteotomy may be able to restore useful hand and arm func­tion in some patients; however, in very severe cases, beyond the scope of biological reconstruc­tion, it may be more appropriate to replace the non-functioning hand with a prosthetic device after elective amputation [10, 11]. This concept of bionic limb replacement has been successfully demonstrated in patients with functionless hands after brachial plexus injuries, massive tissue damage, or congenital deciencies [10, 12, 13].
12.2 Technique
12.2.1 Initial Review
Upper limb function is rst assessed preopera­tively for both range of motion and sensation. Prosthetic replacement with an articial hand requires a stable shoulder, a strong elbow exion, and at least two myosignals at the forearm to open and close a prosthetic hand. Insufcient motor power to move the biological hand and missing sensation represents the main indications for
© Springer Nature Switzerland AG 2019 D. Duscher, M. A. Shiffman (eds.), Regenerative Medicine and Plastic Surgery,
https://doi.org/10.1007/978-3-030-19958-6_12
125
126
https://t.me/medicina_free
prosthetic limb replacement. Importantly, a struc­tured interview with a psychologist is performed to explore patient concerns and adequate coping mechanisms to deal with the loss of extremity function or the event of an elective amputation.
12.2.2 Identication andCreation
ofEMG Signals
Nerve conduction and EMG studies should be per­formed to assess the extent of nerve damage as well as to quantify the EMG activity present in the remaining musculature. If there are two distinct EMG signals, no nerve transfers or muscle trans­plantations are needed. If EMG signals are missing after the initial nerve injury, but muscles in the forearm are still vital, nerve transfers or standard nerve repair can be performed to establish new EMG signals. However, if the forearm presents as a biologic wasteland, either due to long denervation time or other reasons (e.g., ischemia or brosis), then autologous muscle needs to be transplanted to serve as a bioamplier for prosthetic control. This can be achieved by FFMT using the gracilis muscle from the leg and coapting its motor branch to a tar­get nerve within the forearm. The presence of motor axons in the target nerve can be distinguished by using an intraoperative staining method. Still, the presence of a Tinel-Hoffman sign suggests the existence of regenerated bers. In patients with known brachial plexopathy, the brachial plexus is explored surgically and its branches electrically stimulated for motor activity. Once the presence of motor bers is conrmed by intraoperative stain­ing, fascicles of the donor nerve can then be trans­ferred to the target nerve to create a useful EMG signal for prosthetic control. Residual faint muscu­lar activity in other muscle groups can be used as the opposing control signal.
12.2.3 Rehabilitation andEMG-
Signal Training
After nerve transfer surgery, a nerve regeneration period of approximately 3–9 months is needed for motor nerves to reach their targets. Once neu-
S. Salminger et al.
Fig. 12.1 Hybrid hand tting
romuscular activity is recordable, rehabilitation training can be initiated with visual feedback. EMG activity recorded by surface electrodes can be displayed visually on a computer screen and used to train specic muscle activations.
Once patients are comfortable with this feed­back, these signals can be used to control a vir­tual hand. This is especially useful while the non-functioning hand is still in place, as it encourages patients by visualizing prospective prosthetic hand use. Once the patient is familiar with the different prosthetic functions in the vir­tual environment, a “hybrid hand” can be tted, where a prosthetic hand is mounted to a forearm cast onto the non-functioning hand (Fig. This hybrid hand acts as a further rehabilitation tool to encourage condence in myoelectric con­trol prior to amputation.
12.1).
12.2.4 Amputation andProsthetic
Fitting
The prosthetic limb will replace the existing human hand, and as such the positioning should be customized to each patient. Based on the tech­nical needs the adequate distance for amputation was determined between 15 and 17cm distal to the lateral epicondyle. The skin area showing the best sensory capacity is included in the ap design for stump coverage. This results in
12 Bionic Reconstruction: TheNew Frontier
https://t.me/medicina_free
Fig. 12.2 Patient after prosthetic tting
improved comfort and prosthetic feedback for the patient. A compressive garment is used for early edema control. As the forearm of such patients suffering severe brachial plexus injuries is already completely atrophied, prosthetic tting can take place as early as 6weeks post amputa­tion (Fig.12.2).
12.3 Discussion
In some patients an accident may not lead to an amputation, however to a severe nerve injury, which may result in an “inner” amputation, leav­ing the patient with a non-functional and insen­sate hand or arm [10]. Although it is possible to achieve shoulder stability and sufcient elbow function in most of the patients, reconstruction of useful hand function still represent a goal dif­cult to achieve, especially in patients suffering lower root avulsions. Due to accidents dating back decades in some patients, muscle atrophy and complete joint stiffness of the hand, recon­structive procedures are unable to restore useful hand function. In such cases, bionic hand recon­struction was established as a new treatment
127
option to overcome these biological limitations. The proposed concept of bionic hand substitution was also successfully adapted to patients after massive traumatic tissue loss as well as a patient suffering a congenital limb deciency. This new concept of bionic hand replacement is able to restore useful hand function in patients who were beyond any type of biological reconstruction. In these cases hand transplantation represents no option since the reinnervation of the transplanted hand would fail due to the extensive neurological damage.
Still, the functional capacity of a myoelectric prosthetic device can by no means be compared with that of a biologically sound hand. However, in such severe cases, the useful prospective prosthetic hand function justies articial replacement. Still, the prosthetic hand will always act as a helping hand for managing bimanual activities, whereas the prosthesis can take over simple tasks that require brute strength, freeing the sound extremity for demanding dex­terous tasks.
Additionally, in patients suffering severe bra­chial plexus injuries including root avulsions, the chronic pain syndrome, referred to as deaf­ferentation pain, represents an equal burden to the patient as the loss of hand function. In our experience, prosthetic hand replacement leads to a signicant pain relief as a consequence of functional reafferentation and replacement of the phantom limb with a functioning articial hand.
12.4 Conclusions
The presented technique of bionic hand recon­struction overcomes biological limitations of classic reconstructive approaches in patients suf­fering severe injuries leading to a substantial chronic loss of hand function. Future upcoming technological developments will have great impact on signal processing and interpretation for prosthetic control. Due to the reduced number of myosignals in this patient population, pattern recognition or regression algorithms may not be as benecial as for conventional amputees. Still,
128
https://t.me/medicina_free
S. Salminger et al.
these advanced systems may be able to extract more information on the existing faint muscle signals and therefore improve prosthetic function. Additionally, prosthetic control will be improved by implantable electrodes providing consistent high-quality myosignals independent from skin texture or transpiration, amount of subcutaneous fat, or prosthetic socket movements [14]. Although skin sensation is limited in most patients suffering brachial plexus injuries, tactile prosthetic feedback may also be realized, thus enhancing prosthetic use and bodily integrity in future prosthetic systems [15].
References
1. Birch R.Traction lesions of the brachial plexus. Br J Hosp Med. 1984;32:140–3.
2. Bertelli JA, Ghizoni MF. Brachial plexus avulsion injury repairs with nerve transfers and nerve grafts directly implanted into the spinal cord yield par­tial recovery of shoulder and elbow movements. Neurosurgery. 2003;52:1385–9.
3. Soldado F, Ghizoni MF, Bertelli J. Thoracodorsal nerve transfer for elbow exion reconstruction in infraclavicular brachial plexus injuries. J Hand Surg Am. 2014;39:1766–70.
4. Bonney G. Watson-Jones lecture, 1976. Some lesions of the brachial plexus. Ann R Coll Surg Engl. 1977;59:298–306.
5. Bertelli JA, Ghizoni MF.Reconstruction of complete palsies of the adult brachial plexus by root grafting using long grafts and nerve transfers to target nerves. J Hand Surg Am. 2010;35:1640–6.
6. Franzblau L, Chung KC.Psychosocial outcomes and coping after complete avulsion traumatic brachial plexus injury. Disabil Rehabil. 2015;37:135–43.
7. Terzis JK, Kostopoulos VK.Free muscle transfer in posttraumatic plexopathies part II: the elbow. Hand (N Y). 2010;5:160–70.
8. Terzis JK, Barmpitsioti A.Secondary shoulder recon­struction in patients with brachial plexus injuries. J Plast Reconstr Aesthet Surg. 2011;64:843–53.
9. Terzis JK, Barbitsioti A.Primary restoration of elbow exion in adult post-traumatic plexopathy patients. J Plast Reconstr Aesthet Surg. 2012;65:72–84.
10. Aszmann OC, Roche AD, Salminger S, Paternostro­Sluga T, Herceg M, Sturma A, Hofer C, Farina D.Bionic reconstruction to restore hand function after brachial plexus injury: a case series of three patients. Lancet. 2015;385(9983):2183–9.
11. Hruby LA, Sturma A, Mayer JA, Pittermann A, Salminger S, Aszmann OC. Algorithm for bionic hand reconstruction in patients with global brachial plexopathies. J Neurosurg. 2017;17:1–9.
12. Aszmann OC, Vujaklija I, Roche AD, Salminger S, Herceg M, Sturma A, Hruby LA, Pittermann A, Hofer C, Amsuess S, Farina D. Elective amputation and bionic substitution restore functional hand use after critical soft tissue injuries. Sci Rep. 2016;6:34960.
13. Salminger S, Roche AD, Sturma A, Hruby LA, Aszmann OC. Improving arm function by prosthetic limb replacement in a patient with severe arthrogryposis multiplex congenita. J Rehabil Med. 2016;48:725–8.
14. Pasquina PF, Evangelista M, Carvalho AJ, Lockhart J, Grifn S, Nanos G, McKay P, Hansen M, Ipsen D, Vandersea J, Butkus J, Miller M, Murphy I, Hankin D. First-in-man demonstration of a fully implanted myoelectric sensors system to control an advanced electromechanical prosthetic hand. J Neurosci Methods. 2014;244:85–93.
15. Farina D, Aszmann O.Bionic limbs: clinical reality and academic promises. Sci Transl Med. 2014;6(257): 257ps12.
Carbohydrates inRegenerative
https://t.me/medicina_free
Medicine: FromScaolds toCell Fate Modulators
RobertoGuizzardi, MattiaVacchini, andLauraCipolla
13
13.1 Introduction
Regenerative medicine can be dened as a bio­medical eld aimed at regenerating or replacing human cells, tissues, or entire organs for the res­toration of the native functions of impaired part [13]. A synergistic partnership of different ele­ments may be required in order to regenerate body parts: the interplay among suitable natural or articial scaffolds for cells growth, molecular/ physical signals and cells, eventually engineered with different techniques (Fig.13.1).
In the last two decades, tremendous break­through has been achieved in the eld, due to a better understanding of cell biology and the advances in material science, chemistry, and engi­neering strategies, all integrated within a multidis­ciplinary context and boosted by the revolutionary discovery of stem cells and the development of their applications. Plastic surgery practices have nowadays incorporated a large variety of the above-cited key elements of regenerative medi­cine [4]. Natural or articial material scaffolds, standing at the core of regenerative medicine technologies, are devised to modulate cells behav­ior, and can be macroscopically designed to
R. Guizzardi · M. Vacchini · L. Cipolla (*) Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy e-mail: r.guizzardi@campus.unimib.it;
m.vacchini@campus.unimib.it; laura.cipolla@unimib.it
mimic natural tissue mechanical properties (i.e., hardness or elasticity for bone or bladder, veins and arteries, or cartilage respectively). Recently, biomaterial design has reached the nanoscale level, granting the possibility to ne-tune their properties, better mirroring the interactions between cells and the extracellular matrix (ECM) within living organisms, generating more suitable and functional architectures, thus increasing the chances of obtaining concrete biomedical bene­ts. For instance, a good enhancement of cell adhesion, proliferation, and expression of matrix components has been achieved through simply increasing the nanoscaled roughness of the scaf­fold pore walls [5]. This represents the ground level of tuning of biomaterials, and a variety of parameters can be modulated to inuence cells behavior, comprising physical ones, such as mor­phology (i.e., bers, sponges), roughness, topol­ogy, and topography (both at the micro- and nanoscale), and mechanical ones (i.e., stiffness). Upon these premises, new smart biomaterials and biopolymers can be created, such as elastic degradable polymers or polymers with shape memory [6]. Signicant improvements have been made in recent years in understanding how physi­cal properties of biomaterials affect cellular bio­chemical responses. This is principally carried out through mechano-sensing, an active cellular pro­cess involving dynamic interplay between cells and their physical environment, and several stud­ies have shed light on how physical signals potently guide cell fate [7].
© Springer Nature Switzerland AG 2019 D. Duscher, M. A. Shiffman (eds.), Regenerative Medicine and Plastic Surgery,
https://doi.org/10.1007/978-3-030-19958-6_13
129
130
olds
Regulatory Signals
https://t.me/medicina_free
Fig. 13.1 Key elements interplay in regenerative medicine
Cells
Basal programming factors
R. Guizzardi et al.
Material Scaff
iPSCs
Somatic Cells
Differentiated cells
Morfology
In addition to the tuning of nano- and micro­scaled physical, topographical, and mechanical properties, biomaterials can be functionalized with biological signals in order to obtain bioac­tive scaffolds. In this respect, the creation of a biologically active surrounding puts cells in a naturally mimicked or engineered environment towards which they are inherently sensitive and can respond with different and specic behaviors triggered even with epitopes at the molecular level. Thus, the incorporation of bioactive cues may foster the desired cellular response towards tissue regeneration. Several signaling (macro) molecules can be used towards this aim, such as bioactive peptides, whole proteins, or even car­bohydrates. In fact, a cell outer membrane is usu­ally covered by a forest of carbohydrate structures (known as the glycocalyx) and at least six differ­ent receptor systems, which can be activated by interactions with adjacent cells, secreted signal­ing molecules, and specic ligands within the ECM, triggering a plethora of biochemical events, comprising cell adhesion, proliferation, migration, organogenesis, and wound repair.
Metal alloys
E
R
N
A
E
T
G
E
R
E
C
A
L
P
E
R
R
E
S
T
E
O
R
Mechanical properties
E
Ceramics &
Composites
R
E
P
A
I
R
Natural or synthetic
polymers
Biochemical cues
Carbohydrates in particular, in the form of com­plex polysaccharides or smaller epitopes, repre­sent a tremendous resource for regenerative medicine applications that can be exploited directly as building blocks for natural scaffolds or as signaling cues added to the scaffold to better drive cells behavior.
Beyond scaffold bioengineering, enormous advances in cell biology, above all the discovery of human embryonic stem cells (hESCs) [8] and induced pluripotent stem cells (iPS) [9], have strongly broadened the horizons of regenerative medicine. Plastic surgery may benet from regenerative medicine advancement in several elds of applications, such as burn care, nerve regeneration, breast reconstruction, wound heal­ing, scar treatment, hand and face transplanta­tion, bioprosthetic interfaces, bone regeneration, deformities treatments, and skin regeneration. In this chapter we will review recent advances of regenerative medicine based on carbohydrates, from scaffold design and bioactivation, to cell glycoengineering aspects, towards the modula­tion of cellular responses and behaviors.
13 Carbohydrates inRegenerative Medicine: FromScaolds toCell Fate Modulators
https://t.me/medicina_free
131
13.2 Carbohydrate-Based Scaolds
13.2.1 General Issues in Scaold Design
Regardless of the tissue type that needs to be restored, a number of key issues (such as biocom­patibility, biodegradability, and mechanical prop­erties) should be considered in the design of implantable scaffolds for regenerative medicine.
13.2.2 Biocompatibility
First of all, any scaffold for tissue engineering needs to be biocompatible; cells must adhere, maintain their functions, and migrate onto the sur­face. After implantation, the scaffold or tissue­engineered construct must elicit a negligible immune reaction, in order to prevent severe inammatory responses that might reduce healing capacities or cause material rejection by the body.
13.2.3 Biodegradability
Scaffolds and constructs are often not intended as permanent implants. The scaffold must therefore be biodegradable, while cells produce their own renewable extracellular matrix and renovate tis­sues. The by-products of scaffold degradation should be nontoxic, in order to ensure safety of the material, and waste products should be degraded through endogenous cellular metabolism.
while they have to be at the same time biocom­patible, and porous, in order to allow vasculariza­tion. Many materials have been produced with good mechanical properties but to the detriment of retaining a suitable porosity. It is clear that a balance between mechanical properties and porous architecture, required for vascularization and sufcient to allow cell inltration, has to be considered in the design of suitable scaffolds.
These issues are crucial in biomaterial design because mechanical properties, due to the nature of material and its chemistry, need to merge with biocompatibility and suitability for cellular life.
13.2.5 Scaold Architecture
Scaffold architecture used in tissue engineering is a critical issue for surgery applications: gener­ally these materials should have an intercon­nected pore structure and suitable porosity to ensure cell invasion and diffusion of nutrients towards cells. Moreover, a porous and intercon­nected structure is required to allow diffusion of waste products.
The issue of core degradation, arising from lack of vascularization and waste removal from the cen­ter of the engineered tissue constructs, is a major concern in the eld of tissue engineering. Therefore, for any scaffold, a critical range of pore sizes exists which may vary depending on the cell type used and kind of tissue being engineered [10, 11].
13.2.6 Manufacturing Technology
13.2.4 Mechanical Properties
Ideally, the scaffold should have mechanical properties consistent with the anatomical site to be restored and, from a practical perspective, it must be strong enough to allow surgical handling during implantation. Producing scaffolds with adequate mechanical properties is one of the great challenges, for example, in bone tissue regeneration, since strong materials resembling our bone are necessary, which is a nontrivial task,
In order to obtain a particular scaffold or engi­neered tissue construct which can be clinically and commercially viable, creation procedures should be cost effective and scalable up to small batch production [12]. The development of scal­able manufacturing processes to good manufac­turing practice (GMP) standard is critically important in ensuring successful translation of tissue engineering strategies to the clinic [13, 14]. Another key factor is determining how a product will be delivered and made available to clini­cians. This will determine how either the scaffold
132
https://t.me/medicina_free
R. Guizzardi et al.
or the engineered tissue construct will be stored. Clinicians typically prefer off-the-shelf availabil­ity without the requirement for extra surgical pro­cedures in order to harvest cells prior to a number of weeks of invitro culture before implantation. However, for some tissue types, this is not possi­ble and invitro engineering prior to implantation is required.
13.2.7 Material ofChoice
The nal point in scaffolds design, and the one which all of the criteria listed above are depen­dent upon, is the choice of material from which the scaffold should be fabricated.
Different materials have been proposed to be used as both three-dimensional porous scaf­folds and hydrogel matrices for distinct tissue engineering strategies. Typically, three groups of biomaterials, ceramics, synthetic polymers, and natural polymers, are used in the fabrica­tion of scaffolds for tissue engineering [15]. Each of these individual material groups has specic advantages and, needless to say, disad­vantages, so the use of composite scaffolds comprising different phases is becoming increasingly common.
Among materials, polymers of natural origin are one of the most attractive option, in some cases due to their similarities with the extracel­lular matrix (ECM), chemical versatility, as well as good biological performance. An important aspect is the processing of natural materials into porous matrices, a task that usually needs other technologies rather than those commonly employed in the processing of conventional syn­thetic polymers. There are also clinical needs for processing biomaterials into several different shapes, including nano/microparticles (for con­trolled release application), or into two-dimen­sional structures (e.g., membranes as wound dressing).
It should be noted that natural-derived materi­als may result in undesired or unexpected immune reactions while, more generally, inammatory responses may arise from chemical impurities due to production processes.
13.3 Carbohydrate-Based Scaolds
Being carbohydrates widely distributed in nature and performing different biological functions, their use in scaffolds preparation is particularly attractive, offering a variety of potential applica­tions in regenerative medicine. Polysaccharidic materials can be isolated from different sources (plants, animals, microorganisms, algae); they show different biological and physical properties (i.e., solubility, mechanical features, gelling behavior, surface, and interfacial properties) as a function of their monosaccharide composition, chain length and tridimensional conformation, molecular weight, glycosidic bond stereochemis­try, and regiochemistry [16, 17].
Several polysaccharides are already used as
scaffolds in plastic surgery (Table13.1) [18].
Some of them are constituents of the ECM, such as hyaluronic acid, and for this reason in the last decades gained widespread applications in regenerative medicine. In fact, as ECM plays an instructive role in cell functions, the hypothesis is that such biomolecules would maintain the bio­logical information and other physicochemical features, which would preserve the potential of new tissue development after cell seeding. This would help to overcome one of the main draw­backs in the use of synthetic and inorganic mate­rials: lacking of cell recognition signals.
In the following section, a brief overview of polysaccharides and their applications in regen­erative medicine will be given.
13.3.1 Polysaccharides fromAnimal
Sources
13.3.1.1 Hyaluronic Acid (HYA)
Hyaluronic acid (or hyaluronan) is a nonadhesive non-sulfated glycosaminoglycan, found mostly in connective, epithelial, and neural tissue [19]. Hyaluronic acid is a linear polysaccharide com­posed of 250–25,000 β(1→4)-linked disaccha­ride units, consisting of -glucuronic acid and N-acetyl--glucosamine (GlcNAc) linked by β(13) bond. The repeating units of HYA form
13 Carbohydrates inRegenerative Medicine: FromScaolds toCell Fate Modulators
https://t.me/medicina_free
Table 13.1 Commercial polysaccharide-based biomaterials
Products, commercial availability, or sources Materials Uses Advantages/ disadvantages
VivoDerm (ER Squibb and Co, Princeton, New Jersey)
Hyalomatrix PA (Addmedica Paris, France)
Hyalo graft 3D (Fidia Advanced Biopolymers Padova, Italy)
Integra (Integra Life Sciences Corp., Plainsboro, New Jersey)
Algicell Calcium Alginate (Derma Sciences, Princeton, New Jersey); AlgiDERM (Bard Medical, Covington, Georgia); KALTOSTAT (ConvaTec, Skillman, New Jersey); Tegagen (3M, St Paul, Minnesota)
Allevyn (Smith &Nephew, London, United Kingdom); DuoDERM (ConvaTec, Skillman, New Jersey); Hydrocol (Bertek, Rockford, Illinois); InvacareHydrocolloid (Invacare Supply Group, Elyria, Ohio); Tegasorb (3M, St Paul, Minnesota)
Restylane (Medicis, Scottsdale, Arizona)
Hylaform/Hylaform Plus (InamedAesthetics, Santa Barbara, California)
Hyaluronic acid Partial-thickness burns;
Partial benzylester of hyaluronic acid
Esteried hyaluronic acid
Collagen and chondroitin-6­sulfate
Alginates and derivatives
Polycarboxymethyl cellulose and derivatives
Stabilized Hyaluronic acid gel,
Cross-linked molecules of hyaluronic acid
venous and pressure ulcers; vitiligo treatment
Partial-thickness burns; deep burns in children
Full, partial-thickness wounds; scleroderma cutaneous ulcers
Deep partial-thickness and full-thickness burns; post surgical wounds; diabetic ulcers
Deep wounds; autolytic debridement; rope form to pack deep or tunneling wounds; infected wounds
Light to moderate exudate in shallow full-thickness defects; wounds requiring moisture, such as granulation tissue; used under compression dressing; autolytic debridement, especially with necrotic, dry eschar
Mid-dermal applications, such as deeper wrinkle reduction, lip augmentation, nasolabial folds, and glabellar creases; also used in treatment of tear trough deformities
Approved for injection into the mid-dermis to deepdermis for correction of moderate to severe facial wrinkles and folds, subdermal injection lead to inferior results, and if injected too supercially
No apparent rejection; 2-d shelf life; delay in preparation because of graft cultivation
No animal or allogeneic human-derived components
May be combined with Laser Skin technologies for treatment of deep wounds
Bilayered; good barrier function; long shelf life; may be applied over bone; removal of silicone layer and auto graft required; possible uid entrapment beneath construct
Conformable and allows gas exchange; draws out contaminates and excess exudate in heavily draining wounds. May dehydrate wounds with minimal exudate; contraindicated in third-degree burns; need to be changed daily
Reduce pain; its property allows patients to continue daily activity; may leave residue or adhere to wound surfaces; not recommended with heavy exudate, active infection, or sinus tracts; highly occlusive property can promote anaerobic infection
Advantages include minimal hyper sensitivity reactions, easily injected with nice ow through small-gauge needle, long persistence after injection; but include higher cost, higher incidence of bruising, and potential for severe swelling and pain from lack of anesthetic mixture
No skin test is necessary, thus can be used at initial consultation; disadvantages include shorter longevity than other hyaluronic acid products; cannot be used in patients with hypersensitivity to avian proteins, most notably eggs
(continued)
133